دورية أكاديمية

APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

التفاصيل البيبلوغرافية
العنوان: APP/Aβ structural diversity and Alzheimer's disease pathogenesis.
المؤلفون: Roher AE; Division of Neurobiology, Barrow Neurological Institute, Phoenix, AZ 85013, USA; Division of Clinical Education, Midwestern University, Glendale, AZ 85308, USA. Electronic address: aeroher@gmail.com., Kokjohn TA; Department of Microbiology, Midwestern University, Glendale, AZ 85308, USA., Clarke SG; Department of Chemistry and Biochemistry and the Molecular Biology Institute, University of California, Los Angeles, Los Angeles CA 90095-1569, USA., Sierks MR; Department of Chemical Engineering, Arizona State University, Tempe, AZ 85287-6106, USA., Maarouf CL; Laboratory of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA., Serrano GE; Laboratory of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA., Sabbagh MS; Alzheimer's and Memory Disorders Division, Barrow Neurological Institute, Phoenix, AZ 85013, USA., Beach TG; Laboratory of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
المصدر: Neurochemistry international [Neurochem Int] 2017 Nov; Vol. 110, pp. 1-13. Date of Electronic Publication: 2017 Aug 12.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 8006959 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9754 (Electronic) Linking ISSN: 01970186 NLM ISO Abbreviation: Neurochem Int Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford [Elmsford, N. Y.] Pergamon Press.
مواضيع طبية MeSH: Alzheimer Disease/*diagnostic imaging , Alzheimer Disease/*etiology , Amyloid beta-Peptides/*chemistry , Amyloid beta-Protein Precursor/*chemistry, Alzheimer Disease/metabolism ; Amyloid beta-Peptides/analysis ; Amyloid beta-Peptides/metabolism ; Amyloid beta-Protein Precursor/analysis ; Amyloid beta-Protein Precursor/metabolism ; Animals ; Brain/metabolism ; Brain/pathology ; Humans ; Plaque, Amyloid/complications ; Plaque, Amyloid/diagnostic imaging ; Plaque, Amyloid/metabolism
مستخلص: The amyloid cascade hypothesis of Alzheimer's disease (AD) proposes amyloid- β (Aβ) is a chief pathological element of dementia. AD therapies have targeted monomeric and oligomeric Aβ 1-40 and 1-42 peptides. However, alternative APP proteolytic processing produces a complex roster of Aβ species. In addition, Aβ peptides are subject to extensive posttranslational modification (PTM). We propose that amplified production of some APP/Aβ species, perhaps exacerbated by differential gene expression and reduced peptide degradation, creates a diverse spectrum of modified species which disrupt brain homeostasis and accelerate AD neurodegeneration. We surveyed the literature to catalog Aβ PTM including species with isoAsp at positions 7 and 23 which may phenocopy the Tottori and Iowa Aβ mutations that result in early onset AD. We speculate that accumulation of these alterations induce changes in secondary and tertiary structure of Aβ that favor increased toxicity, and seeding and propagation in sporadic AD. Additionally, amyloid-β peptides with a pyroglutamate modification at position 3 and oxidation of Met35 make up a substantial portion of sporadic AD amyloid deposits. The intrinsic physical properties of these species, including resistance to degradation, an enhanced aggregation rate, increased neurotoxicity, and association with behavioral deficits, suggest their emergence is linked to dementia. The generation of specific 3D-molecular conformations of Aβ impart unique biophysical properties and a capacity to seed the prion-like global transmission of amyloid through the brain. The accumulation of rogue Aβ ultimately contributes to the destruction of vascular walls, neurons and glial cells culminating in dementia. A systematic examination of Aβ PTM and the analysis of the toxicity that they induced may help create essential biomarkers to more precisely stage AD pathology, design countermeasures and gauge the impacts of interventions.
(Copyright © 2017 Elsevier Ltd. All rights reserved.)
References: Neurology. 2016 Aug 2;87(5):539-47. (PMID: 27371494)
Neuroreport. 2001 Dec 4;12(17):3839-44. (PMID: 11726805)
Biochem Biophys Res Commun. 2000 Feb 24;268(3):750-6. (PMID: 10679277)
Annu Rev Genet. 2013;47:601-23. (PMID: 24274755)
Front Aging Neurosci. 2014 Oct 20;6:290. (PMID: 25368578)
Integr Biol (Camb). 2011 Dec;3(12):1188-96. (PMID: 22076255)
J Biol Chem. 2016 Nov 11;291(46):24041-24053. (PMID: 27687728)
J Neurosci. 2005 Jan 12;25(2):436-45. (PMID: 15647487)
Biochem J. 2013 Dec 15;456(3):347-60. (PMID: 24028142)
Bioorg Med Chem Lett. 1999 Apr 5;9(7):953-6. (PMID: 10230618)
Mol Med. 2008 Mar-Apr;14(3-4):184-94. (PMID: 18317569)
Am J Pathol. 2006 Sep;169(3):1048-63. (PMID: 16936277)
Cell. 2007 Oct 19;131(2):215-21. (PMID: 17956719)
Ann Neurol. 2013 Sep;74(3):478-89. (PMID: 23798485)
EMBO J. 1988 May;7(5):1365-70. (PMID: 2900758)
J Biol Chem. 1993 Feb 15;268(5):3072-83. (PMID: 8428986)
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53. (PMID: 9600986)
EMBO J. 2011 Jun 1;30(11):2255-65. (PMID: 21527912)
J Neuropathol Exp Neurol. 2012 May;71(5):362-81. (PMID: 22487856)
Nat Commun. 2016 Mar 07;7:10918. (PMID: 26948379)
Biochemistry. 2006 Sep 26;45(38):11532-9. (PMID: 16981713)
FASEB J. 2005 Nov;19(13):1905-7. (PMID: 16162853)
Biochim Biophys Acta. 1998 Apr 28;1406(3):291-8. (PMID: 9630681)
Biochemistry. 2004 Mar 16;43(10):2871-8. (PMID: 15005622)
Curr Alzheimer Res. 2006 Feb;3(1):75-80. (PMID: 16472207)
J Biol Chem. 1996 Dec 20;271(51):32916-22. (PMID: 8955133)
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):4012-7. (PMID: 19228947)
J Alzheimers Dis. 2009;16(2):211-24. (PMID: 19221413)
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6538-43. (PMID: 20308552)
J Neurochem. 2011 Mar;116(5):806-12. (PMID: 21214549)
J Biol Chem. 1994 Apr 15;269(15):10987-90. (PMID: 8157623)
J Biol Chem. 1995 Oct 13;270(41):23895-8. (PMID: 7592576)
J Neurosci. 1996 Feb 1;16(3):899-908. (PMID: 8558258)
Biochim Biophys Acta. 2010 Oct;1802(10):847-59. (PMID: 20471477)
J Neurosci. 2009 Oct 14;29(41):13042-52. (PMID: 19828817)
J Neurosci Res. 2002 Nov 1;70(3):474-83. (PMID: 12391608)
Free Radic Biol Med. 2010 Jan 1;48(1):136-44. (PMID: 19854267)
J Pept Sci. 2012 Nov;18(11):691-5. (PMID: 23001756)
Chem Res Toxicol. 2015 Mar 16;28(3):401-7. (PMID: 25387246)
Arch Biochem Biophys. 2014 Mar 1;545:44-52. (PMID: 24418316)
J Neuropathol Exp Neurol. 2001 Aug;60(8):778-85. (PMID: 11487052)
EMBO Mol Med. 2016 Jun 01;8(6):595-608. (PMID: 27025652)
Am J Pathol. 1989 Oct;135(4):593-7. (PMID: 2679112)
Exp Neurol. 2009 Aug;218(2):286-92. (PMID: 19358844)
Nat Rev Neurosci. 2007 Jul;8(7):499-509. (PMID: 17551515)
Eur J Neurosci. 2016 Jan;43(1):3-16. (PMID: 26332448)
Protein Eng. 1998 Sep;11(9):761-7. (PMID: 9796824)
J Neuropathol Exp Neurol. 1998 Nov;57(11):1089-95. (PMID: 9825946)
Peptides. 2002 Jul;23(7):1299-309. (PMID: 12128086)
J Biol Chem. 2007 Feb 16;282(7):4916-4923. (PMID: 17170111)
Nat Rev Neurol. 2013 Mar;9(3):123-4. (PMID: 23399647)
J Alzheimers Dis. 2012;28(4):783-94. (PMID: 22064070)
Biochemistry. 2011 Jun 14;50(23):5154-62. (PMID: 21553928)
J Neuropathol Exp Neurol. 2012 Apr;71(4):266-73. (PMID: 22437338)
Biochemistry. 2004 Jun 8;43(22):6959-67. (PMID: 15170333)
Nat Neurosci. 2015 Jun;18(6):794-9. (PMID: 26007212)
Acta Neuropathol. 2013 May;125(5):699-709. (PMID: 23525537)
Biochemistry. 1999 Aug 17;38(33):10871-7. (PMID: 10451383)
Neurobiol Aging. 2008 Sep;29(9):1319-33. (PMID: 17459527)
J Biol Chem. 1996 Feb 23;271(8):4077-81. (PMID: 8626743)
Behav Brain Res. 2008 Sep 1;192(1):106-13. (PMID: 18359102)
Cell. 1988 Feb 26;52(4):487-501. (PMID: 3257719)
Biochemistry. 2005 Aug 16;44(32):10810-21. (PMID: 16086583)
Biotechnol Prog. 2013 Mar-Apr;29(2):463-71. (PMID: 23359572)
Nature. 2013 Sep 5;501(7465):45-51. (PMID: 24005412)
J Am Chem Soc. 2016 Jul 13;138(27):8328-31. (PMID: 27281497)
Int J Pept Protein Res. 1996 Apr;47(4):289-96. (PMID: 8738655)
Pharmazie. 2011 Jul;66(7):529-34. (PMID: 21812329)
FEBS Lett. 2006 Oct 30;580(25):5941-6. (PMID: 17046756)
Biochemistry. 2015 Sep 22;54(37):5781. (PMID: 26348101)
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11858-63. (PMID: 26351699)
Neurobiol Aging. 2012 Jan;33(1):196.e29-40. (PMID: 20619937)
J Biol Chem. 1999 Sep 3;274(36):25945-52. (PMID: 10464339)
Biol Chem. 2008 Aug;389(8):1055-66. (PMID: 18979630)
Biochem Biophys Res Commun. 1994 May 16;200(3):1598-603. (PMID: 8185615)
Nat Med. 2003 Apr;9(4):448-52. (PMID: 12640446)
Nat Med. 2008 Aug;14(8):837-42. (PMID: 18568035)
Biochem Biophys Res Commun. 1997 Aug 8;237(1):188-91. (PMID: 9266855)
Nature. 2002 Apr 4;416(6880):535-9. (PMID: 11932745)
Elife. 2015 Sep 29;4:. (PMID: 26418743)
Science. 2012 Jun 22;336(6088):1511-3. (PMID: 22723400)
J Mol Biol. 1999 Jun 4;289(2):413-28. (PMID: 10366514)
J Neuropathol Exp Neurol. 2002 Feb;61(2):125-31. (PMID: 11855381)
Neuron. 1992 Jan;8(1):159-68. (PMID: 1530909)
Mol Neurobiol. 2010 Jun;41(2-3):138-48. (PMID: 20437210)
Neurobiol Aging. 2014 Apr;35(4):802-7. (PMID: 24199960)
J Biol Chem. 1997 Aug 22;272(34):21037-44. (PMID: 9261105)
J Neurochem. 2002 Sep;82(6):1480-9. (PMID: 12354296)
Am J Pathol. 1996 Dec;149(6):1823-30. (PMID: 8952519)
Biochemistry. 2006 Oct 17;45(41):12393-9. (PMID: 17029395)
J Pept Sci. 2005 Jun;11(6):353-60. (PMID: 15635660)
Sci Rep. 2015 Aug 27;5:13489. (PMID: 26311128)
Nat Med. 1997 Sep;3(9):1016-20. (PMID: 9288729)
Nat Commun. 2015 Nov 09;6:8762. (PMID: 26549211)
Age (Dordr). 2013 Jun;35(3):673-87. (PMID: 22477259)
J Neurosci. 2005 Jan 19;25(3):672-9. (PMID: 15659604)
Acta Neuropathol. 2013 Apr;125(4):549-64. (PMID: 23354835)
Eur J Biochem. 1994 Dec 15;226(3):917-24. (PMID: 7813483)
J Biol Chem. 1996 Dec 27;271(52):33623-31. (PMID: 8969231)
J Neurochem. 2004 Dec;91(6):1398-403. (PMID: 15584916)
Nature. 2015 Oct 15;526(7573):443-7. (PMID: 26322584)
Neurobiol Aging. 2012 Jul;33(7):1320-8. (PMID: 21067847)
J Biol Chem. 2004 Aug 27;279(35):37061-8. (PMID: 15220353)
Biol Pharm Bull. 2005 Sep;28(9):1590-6. (PMID: 16141521)
J Neurosci. 2008 May 14;28(20):5312-20. (PMID: 18480287)
Chem Biol. 1997 Feb;4(2):119-25. (PMID: 9190286)
Brain Pathol. 2010 Jan;20(1):66-79. (PMID: 19021630)
J Biol Chem. 2010 Dec 31;285(53):41517-24. (PMID: 20971852)
Nat Med. 1996 Jan;2(1):93-5. (PMID: 8564851)
Biopolymers. 2009 Oct;91(10):861-73. (PMID: 19562755)
J Neurosci. 2008 Nov 12;28(46):11950-8. (PMID: 19005060)
Nat Rev Neurol. 2016 Feb;12(2):117-24. (PMID: 26782335)
Neurology. 2006 Jan 10;66(1):49-55. (PMID: 16401845)
Brain Pathol. 2008 Apr;18(2):240-52. (PMID: 18363935)
J Alzheimers Dis. 2013;33 Suppl 1:S49-65. (PMID: 22785404)
Am J Pathol. 2010 Apr;176(4):1841-54. (PMID: 20228223)
Nat Med. 2003 Jul;9(7):907-13. (PMID: 12808450)
J Neurosci. 2006 May 31;26(22):6011-8. (PMID: 16738244)
Biosci Biotechnol Biochem. 2013;77(2):416-8. (PMID: 23391937)
Nat Med. 2000 Apr;6(4):397-404. (PMID: 10742146)
J Biol Chem. 2011 Nov 11;286(45):38825-32. (PMID: 21965666)
Nat Neurosci. 2010 Jul;13(7):812-8. (PMID: 20581818)
Ann Neurol. 2011 Jan;69(1):181-92. (PMID: 21280088)
Neuron. 2011 Sep 8;71(5):833-44. (PMID: 21903077)
Neuroreport. 2007 Apr 16;18(6):559-63. (PMID: 17413657)
Subcell Biochem. 2005;38:381-402. (PMID: 15709490)
Brain Res Bull. 1999 Sep 15;50(2):133-41. (PMID: 10535332)
Am J Pathol. 1996 Aug;149(2):585-96. (PMID: 8701997)
J Biol Chem. 1999 Jun 4;274(23):15990-5. (PMID: 10347147)
J Neurosci. 1996 Nov 1;16(21):6732-41. (PMID: 8824314)
J Neurosci. 2014 Jul 30;34(31):10264-73. (PMID: 25080588)
Biochemistry. 2010 Jun 1;49(21):4501-8. (PMID: 20429609)
Elife. 2015 Feb 04;4:. (PMID: 25650802)
Am J Pathol. 1999 Sep;155(3):853-62. (PMID: 10487842)
Biochemistry. 2011 Dec 13;50(49):10687-97. (PMID: 22059533)
Brain Res. 2012 Apr 23;1450:138-47. (PMID: 22440675)
Sci Rep. 2013 Oct 07;3:2880. (PMID: 24096987)
J Neuropathol Exp Neurol. 2003 Mar;62(3):248-59. (PMID: 12638729)
J Biol Chem. 2009 Apr 24;284(17):11048-58. (PMID: 19141614)
Nature. 2009 Feb 19;457(7232):981-9. (PMID: 19225519)
J Mol Biol. 2007 May 11;368(4):1132-44. (PMID: 17391701)
Arch Biochem Biophys. 2000 Sep 15;381(2):225-34. (PMID: 11032409)
Acta Neuropathol Commun. 2015 Nov 10;3:70. (PMID: 26556230)
Eur J Biochem. 1991 Oct 1;201(1):61-9. (PMID: 1915378)
Vascul Pharmacol. 2002 Jun;38(6):303-13. (PMID: 12529925)
Biochem Biophys Res Commun. 1995 Jun 26;211(3):1015-22. (PMID: 7598687)
Curr Neurol Neurosci Rep. 2013 Dec;13(12):412. (PMID: 24136459)
J Neurochem. 1996 Jul;67(1):294-301. (PMID: 8667005)
Science. 2003 Apr 18;300(5618):486-9. (PMID: 12702875)
Neuron. 2012 Dec 6;76(5):908-20. (PMID: 23217740)
J Mol Biol. 2008 Dec 26;384(4):917-28. (PMID: 18929576)
J Chem Theory Comput. 2013 Jan 8;9(1):822-833. (PMID: 23316126)
EBioMedicine. 2016 Apr;6:42-49. (PMID: 27211547)
Brain Res. 2005 Jan 21;1031(2):222-8. (PMID: 15649447)
Inorg Chem. 2011 Nov 7;50(21):11192-201. (PMID: 21980910)
J Biol Chem. 1987 Jan 15;262(2):785-94. (PMID: 3805008)
J Biol Chem. 2006 Feb 17;281(7):4292-9. (PMID: 16361260)
Biochem Pharmacol. 2013 Feb 1;85(3):289-305. (PMID: 23178653)
Mol Neurodegener. 2010 Oct 07;5:39. (PMID: 20929585)
Neurobiol Aging. 1994 Sep-Oct;15(5):621-7. (PMID: 7824054)
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5819-24. (PMID: 21421841)
Brain Res. 2002 Jan 11;924(2):133-40. (PMID: 11750898)
Acta Neuropathol. 2010 Aug;120(2):185-93. (PMID: 20419305)
Neurobiol Aging. 2004 May-Jun;25(5):569-80. (PMID: 15172732)
Neuron. 1995 Feb;14(2):457-66. (PMID: 7857653)
Mol Neurodegener. 2014 Nov 14;9:48. (PMID: 25394486)
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10836-40. (PMID: 8248178)
Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):150-62. (PMID: 10095087)
J Biol Chem. 2002 Oct 25;277(43):40173-6. (PMID: 12198111)
Biochem Biophys Res Commun. 2009 Oct 16;388(2):450-5. (PMID: 19679105)
Am J Pathol. 2000 Mar;156(3):797-805. (PMID: 10702395)
Biochem Biophys Res Commun. 2000 Sep 24;276(2):422-7. (PMID: 11027491)
J Neurochem. 2012 Jun;121(5):774-84. (PMID: 22375951)
Neuron. 2014 Apr 16;82(2):308-19. (PMID: 24685176)
Curr Pharm Des. 2014;20(15):2491-505. (PMID: 23859553)
J Neuropathol Exp Neurol. 2006 Nov;65(11):1040-8. (PMID: 17086100)
Phys Chem Chem Phys. 2013 Jun 21;15(23):8878-89. (PMID: 23493873)
Ann Neurol. 1999 Dec;46(6):860-6. (PMID: 10589538)
Trends Neurosci. 2008 Sep;31(9):454-63. (PMID: 18675468)
J Biol Chem. 2004 Dec 3;279(49):50647-50. (PMID: 15485850)
Protein Eng Des Sel. 2006 Nov;19(11):497-502. (PMID: 16984950)
Acta Neuropathol. 2003 Mar;105(3):252-8. (PMID: 12557012)
Alzheimers Res Ther. 2014 May 26;6(3):28. (PMID: 25031638)
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10323-8. (PMID: 24982139)
J Neuropathol Exp Neurol. 1998 Jan;57(1):76-94. (PMID: 9600199)
J Mol Biol. 2012 Aug 24;421(4-5):427-40. (PMID: 22248587)
Nature. 2012 May 02;485(7400):651-5. (PMID: 22660329)
J Alzheimers Dis. 2012;29(2):361-71. (PMID: 22232007)
J Biol Chem. 1992 Aug 25;267(24):17082-6. (PMID: 1512246)
ACS Chem Neurosci. 2013 Nov 20;4(11):1446-57. (PMID: 24041307)
J Neurosci. 2004 Nov 10;24(45):10191-200. (PMID: 15537891)
J Biol Chem. 2010 Jul 23;285(30):23186-97. (PMID: 20452980)
Neurol Res. 2005 Dec;27(8):869-81. (PMID: 16354549)
J Biol Chem. 2016 Sep 9;291(37):19235-44. (PMID: 27474742)
Neurology. 2005 Jan 11;64(1):129-31. (PMID: 15642916)
Hypertension. 2012 Jul;60(1):188-97. (PMID: 22615109)
Mol Ther. 2004 Dec;10(6):1023-31. (PMID: 15564134)
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a006262. (PMID: 22675658)
Anal Chem. 2014 Jan 7;86(1):797-804. (PMID: 24283798)
J Neurochem. 2003 Jun;85(6):1581-91. (PMID: 12787077)
Alzheimers Dement. 2009 Jan;5(1):18-29. (PMID: 19118806)
Eur J Biochem. 1994 May 1;221(3):959-64. (PMID: 8181478)
J Neurochem. 2012 Jan;120 Suppl 1:125-139. (PMID: 22121920)
Neuroscience. 2001;104(4):1003-11. (PMID: 11457586)
J Biol Chem. 1996 Aug 23;271(34):20631-5. (PMID: 8702810)
Int J Biochem Cell Biol. 2010 Dec;42(12):1915-8. (PMID: 20833262)
FEBS J. 2011 Oct;278(20):3905-17. (PMID: 21722314)
Neurobiol Aging. 2001 Nov-Dec;22(6):931-6. (PMID: 11755001)
Ann Neurol. 2008 Feb;63(2):204-12. (PMID: 17894374)
Biochim Biophys Acta. 2011 Nov;1812(11):1508-14. (PMID: 21784149)
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338. (PMID: 22762015)
J Biol Chem. 2004 Oct 29;279(44):45897-908. (PMID: 15322125)
Lancet. 2008 Jul 19;372(9634):216-23. (PMID: 18640458)
Curr Neuropharmacol. 2013 Sep;11(5):491-8. (PMID: 24403873)
J Alzheimers Dis. 2013;37(1):9-18. (PMID: 23719512)
Neurodegener Dis. 2012;10(1-4):265-70. (PMID: 22343072)
Brain Pathol. 2004 Jan;14(1):11-20. (PMID: 14997933)
Curr Pharm Des. 2014;20(15):2506-19. (PMID: 23859546)
ACS Chem Neurosci. 2015 Dec 16;6(12):1941-55. (PMID: 26421877)
EMBO Rep. 2007 Feb;8(2):136-40. (PMID: 17268504)
J Biol Chem. 1991 Oct 15;266(29):19396-406. (PMID: 1833402)
Mol Cell Neurosci. 2001 Nov;18(5):503-11. (PMID: 11922141)
J Proteome Res. 2009 Oct;8(10):4615-21. (PMID: 19663459)
Science. 2015 Oct 2;350(6256):94-98. (PMID: 26430121)
FEBS Lett. 1997 Jun 16;409(3):411-6. (PMID: 9224700)
J Neuropathol Exp Neurol. 2015 Sep;74(9):934-42. (PMID: 26230581)
معلومات مُعتمدة: P30 AG019610 United States AG NIA NIH HHS; R01 AG019795 United States AG NIA NIH HHS; U24 NS072026 United States NS NINDS NIH HHS
المشرفين على المادة: 0 (Amyloid beta-Peptides)
0 (Amyloid beta-Protein Precursor)
تواريخ الأحداث: Date Created: 20170817 Date Completed: 20180606 Latest Revision: 20240610
رمز التحديث: 20240610
مُعرف محوري في PubMed: PMC5688956
DOI: 10.1016/j.neuint.2017.08.007
PMID: 28811267
قاعدة البيانات: MEDLINE